Endo International Plc
(NASDAQ : ENDP)

( )
ENDP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.48%166.090.7%$1108.87m
PFEPfizer Inc. -0.72%49.750.9%$939.86m
ABBVAbbVie, Inc. -0.22%142.291.9%$831.12m
MRKMerck & Co., Inc. -0.47%90.590.7%$806.25m
LLYEli Lilly & Co. 1.90%313.931.1%$798.53m
BMYBristol-Myers Squibb Co. -1.36%74.541.0%$648.45m
SIGASIGA Technologies, Inc. 5.66%26.150.0%$514.56m
AZNAstraZeneca Plc 0.26%66.811.0%$373.58m
GBTGlobal Blood Therapeutics, Inc. 0.43%67.045.6%$334.64m
ALNYAlnylam Pharmaceuticals, Inc. -1.21%231.018.2%$285.62m
GSKGSK Plc -3.08%34.920.3%$275.20m
HZNPHorizon Therapeutics Plc -3.81%64.905.4%$222.52m
KRTXKaruna Therapeutics, Inc. -1.34%273.710.0%$217.12m
CCXIChemoCentryx, Inc. 0.18%50.812.9%$205.42m
RGENRepligen Corp. 1.74%255.736.7%$190.66m

Company Profile

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.